As the global population ages, some analysts believe there are investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.
"Cancer poses notable investment opportunities," Citigroup said last week in a report that advised investing in China cancer plays.
"This market segment is emerging as one of the largest and fastest-growing therapeutic categories," it said.
Read More What do Americans spend fighting cancer?
China's current cancer market is around 65 billion yuan ($10.46 billion), with the 2010-13 compound annual growth rate at more than 17 percent, Citigroup estimated. It expects cancer cases to continue increasing, driven by the aging population and environmental changes.
"The age structure is one of the key indicators for cancer demographics. In general, cancer incidence increased notably in people aged 45 and above," it said.